ClearLine MD said today that it won CE Mark approval for its ClearLine IV product line that prevents air from being introduced into intravenous lines.
During IV infusion, ClearLine’s device detects air in the IV line using ultrasound and then removes the air to allow the fluid to flow continuously. Air embolisms can cause long-term clinical complications such as extended hospital stays and medical liability costs. According to the Centers for Medicare & Medicaid Services, air embolism is the 2nd most serious, preventable adverse hospital event.
Get the full story at our sister site, Drug Delivery Business News.
The post ClearLine wins CE Mark for intravenous line device appeared first on MassDevice.
from MassDevice http://ift.tt/2hACrfP
Cap comentari:
Publica un comentari a l'entrada